Zobrazeno 1 - 10
of 311
pro vyhledávání: '"Bezunartea J"'
Autor:
Hernandez M; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, Navarra Institute for Health Research, IdiSNA, (RICORS-TERAV), 31008 Pamplona, Spain., Recalde S; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, Navarra Institute for Health Research, IdiSNA, (RICORS-TERAV), 31008 Pamplona, Spain., Bezunartea J; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, Navarra Institute for Health Research, IdiSNA, (RICORS-TERAV), 31008 Pamplona, Spain., Moreno-Orduña M; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain., Belza I; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain., Chas-Prat A; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, Navarra Institute for Health Research, IdiSNA, (RICORS-TERAV), 31008 Pamplona, Spain., Perugini E; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain., Garcia-Layana A; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, Navarra Institute for Health Research, IdiSNA, (RICORS-TERAV), 31008 Pamplona, Spain., Fernández-Robredo P; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, Navarra Institute for Health Research, IdiSNA, (RICORS-TERAV), 31008 Pamplona, Spain.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2024 Jul 24; Vol. 25 (15). Date of Electronic Publication: 2024 Jul 24.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
González-Zamora J; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain., Hernandez M; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Navarra Institute for Health Research, IdiSNA, Clinica Universidad de Navarra, 31008 Pamplona, Spain., Recalde S; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Navarra Institute for Health Research, IdiSNA, Clinica Universidad de Navarra, 31008 Pamplona, Spain., Bezunartea J; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Navarra Institute for Health Research, IdiSNA, Clinica Universidad de Navarra, 31008 Pamplona, Spain., Montoliu A; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain., Bilbao-Malavé V; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain., Llorente-González S; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Navarra Institute for Health Research, IdiSNA, Clinica Universidad de Navarra, 31008 Pamplona, Spain., García-Layana A; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Navarra Institute for Health Research, IdiSNA, Clinica Universidad de Navarra, 31008 Pamplona, Spain., Fernández-Robredo P; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Navarra Institute for Health Research, IdiSNA, Clinica Universidad de Navarra, 31008 Pamplona, Spain.
Publikováno v:
Antioxidants (Basel, Switzerland) [Antioxidants (Basel)] 2023 Apr 05; Vol. 12 (4). Date of Electronic Publication: 2023 Apr 05.
Autor:
Bilbao-Malavé V; Department of Opthalmology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Universidad de Navarra, 31008 Pamplona, Spain., González-Zamora J; Department of Opthalmology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Universidad de Navarra, 31008 Pamplona, Spain., Gándara E; Department of Opthalmology, Clínica Universidad de Navarra, 31008 Pamplona, Spain., de la Puente M; Department of Opthalmology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Universidad de Navarra, 31008 Pamplona, Spain., Escriche E; Faculty of Medicine, Universidad de Navarra, 31008 Pamplona, Spain., Bezunartea J; Department of Opthalmology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain.; Red Temática de Investigación Cooperativa en Salud (RD16/0008/0011), Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III, 28029 Madrid, Spain., Marizkurrena A; Department of Opthalmology, Clínica Universidad de Navarra, 31008 Pamplona, Spain., Alonso E; Department of Opthalmology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain.; Red Temática de Investigación Cooperativa en Salud (RD16/0008/0011), Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III, 28029 Madrid, Spain., Hernández M; Department of Opthalmology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain.; Red Temática de Investigación Cooperativa en Salud (RD16/0008/0011), Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III, 28029 Madrid, Spain., Fernández-Robredo P; Department of Opthalmology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain.; Red Temática de Investigación Cooperativa en Salud (RD16/0008/0011), Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III, 28029 Madrid, Spain., Sáenz de Viteri M; Department of Opthalmology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain.; Red Temática de Investigación Cooperativa en Salud (RD16/0008/0011), Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III, 28029 Madrid, Spain., Barrio-Barrio J; Department of Opthalmology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain.; Red Temática de Investigación Cooperativa en Salud (RD16/0008/0011), Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III, 28029 Madrid, Spain., García-Layana A; Department of Opthalmology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain.; Red Temática de Investigación Cooperativa en Salud (RD16/0008/0011), Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III, 28029 Madrid, Spain., Recalde S; Department of Opthalmology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain.; Red Temática de Investigación Cooperativa en Salud (RD16/0008/0011), Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2022 Jul 22; Vol. 11 (15). Date of Electronic Publication: 2022 Jul 22.
Autor:
González-Zamora J; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain., Hernandez M; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain., Recalde S; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain., Bezunartea J; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain., Montoliu A; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain., Bilbao-Malavé V; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain., Orbe J; Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain.; Laboratory of Atherothrombosis, Program of Cardiovascular Diseases, CIMA-Universidad de Navarra, CIBERCV, 31008 Pamplona, Spain., Rodríguez JA; Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain.; Laboratory of Atherothrombosis, Program of Cardiovascular Diseases, CIMA-Universidad de Navarra, CIBERCV, 31008 Pamplona, Spain., Llorente-González S; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain., Fernández-Robredo P; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain., García-Layana A; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain.
Publikováno v:
Biomedicines [Biomedicines] 2022 Jun 30; Vol. 10 (7). Date of Electronic Publication: 2022 Jun 30.
Autor:
López-Muneta L; Regenerative Medicine Program, Foundation for Applied Medical Research (CIMA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), University of Navarra, Pamplona, Spain., Linares J; Regenerative Medicine Program, Foundation for Applied Medical Research (CIMA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), University of Navarra, Pamplona, Spain., Casis O; Departament of Physiology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain., Martínez-Ibáñez L; Program of Cardiovascular Diseases, Foundation for Applied Medical Research (CIMA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), University of Navarra, Pamplona, Spain., González Miqueo A; Program of Cardiovascular Diseases, Foundation for Applied Medical Research (CIMA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), University of Navarra, Pamplona, Spain.; Centro de Investigación Biomédica en Red Cardiovascular (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain., Bezunartea J; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, University of Navarra Clinic, Pamplona, Spain., Sanchez de la Nava AM; Department of Cardiology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Madrid, Spain.; Centro de Investigación Biomedica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain., Gallego M; Departament of Physiology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain., Fernández-Santos ME; Department of Cardiology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Madrid, Spain.; Centro de Investigación Biomedica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain., Rodriguez-Madoz JR; Hemato-oncology Program, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Pamplona, Spain., Aranguren XL; Regenerative Medicine Program, Foundation for Applied Medical Research (CIMA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), University of Navarra, Pamplona, Spain., Fernández-Avilés F; Department of Cardiology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Madrid, Spain.; Centro de Investigación Biomedica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.; Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain., Segovia JC; Cell Technology Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.; Unidad Mixta de Terapias Avanzadas, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain., Prósper F; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Department of Hematology and Cell Therapy, University of Navarra Clinic, Pamplona, Spain., Carvajal-Vergara X; Regenerative Medicine Program, Foundation for Applied Medical Research (CIMA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), University of Navarra, Pamplona, Spain.
Publikováno v:
Frontiers in cell and developmental biology [Front Cell Dev Biol] 2022 Jan 21; Vol. 9, pp. 797927. Date of Electronic Publication: 2022 Jan 21 (Print Publication: 2021).
Autor:
Calvo-Maroto AM; Department of Ophthalmology, Clínica Universidad de Navarra, 28027 Madrid, Spain., Llorente-González S; Department of Ophthalmology, Clínica Universidad de Navarra, 28027 Madrid, Spain.; Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clínica Universidad de Navarra, IdiSNA, 31008 Pamplona, Spain.; Red Temática de Investigación Cooperativa Sanitaria en Enfermedades Oculares, Oftared, ISCIII, 28040 Madrid, Spain., Bezunartea-Bezunartea J; Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clínica Universidad de Navarra, IdiSNA, 31008 Pamplona, Spain.; Red Temática de Investigación Cooperativa Sanitaria en Enfermedades Oculares, Oftared, ISCIII, 28040 Madrid, Spain.; Department of Ophthalmology, Clínica Universidad de Navarra, 31008 Pamplona, Spain., Hurtado-Ceña FJ; Department of Pediatric Ophthalmology, Clínica Rementería, 28010 Madrid, Spain., Berrozpe-Villabona C; Department of Preventive Medicine, Public Health and Health Management, Miguel Servet University Hospital, 50009 Zaragoza, Spain., Bilbao-Malavé V; Department of Ophthalmology, Bellvitge University Hospital, 08907 Barcelona, Spain., Piñero DP; Department of Optics, Pharmacology and Anatomy, University of Alicante, 03690 Alicante, Spain., Barrio-Barrio J; Red Temática de Investigación Cooperativa Sanitaria en Enfermedades Oculares, Oftared, ISCIII, 28040 Madrid, Spain.; Department of Ophthalmology, Clínica Universidad de Navarra, 31008 Pamplona, Spain., Recalde-Maestre S; Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clínica Universidad de Navarra, IdiSNA, 31008 Pamplona, Spain.; Department of Ophthalmology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
Publikováno v:
Children (Basel, Switzerland) [Children (Basel)] 2022 Jan 09; Vol. 9 (1). Date of Electronic Publication: 2022 Jan 09.
Autor:
Casales E; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Av. Pio XII 55, 31008, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain., Martisova E; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Av. Pio XII 55, 31008, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain., Villanueva H; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain.; Aptamer Platform, Molecular Therapeutics Program, Cima Universidad de Navarra, Pamplona, Spain., de Cerio ALD; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain.; Department of Hematology and Cell Therapy Area, Department of Immunology and Immunotherapy, University Clinic of Navarra, Pamplona, Spain., Inoges S; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain.; Department of Hematology and Cell Therapy Area, Department of Immunology and Immunotherapy, University Clinic of Navarra, Pamplona, Spain., Silva-Pilipich N; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Av. Pio XII 55, 31008, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain., Ballesteros-Briones MC; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Av. Pio XII 55, 31008, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain., Aranda A; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Av. Pio XII 55, 31008, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain., Bezunartea J; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Av. Pio XII 55, 31008, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain., Bendandi M; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain.; Department of Hematology and Cell Therapy Area, Department of Immunology and Immunotherapy, University Clinic of Navarra, Pamplona, Spain.; Section On Hematology/Oncology, Wake Forest University Comprehensive Cancer Center, Winston-Salem, NC, USA.; Section of Hematology/Oncology, VA Medical Center, Salisbury, NC, USA., Pastor F; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain.; Aptamer Platform, Molecular Therapeutics Program, Cima Universidad de Navarra, Pamplona, Spain., Smerdou C; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Av. Pio XII 55, 31008, Pamplona, Spain. csmerdou@unav.es.; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain. csmerdou@unav.es.
Publikováno v:
Scientific reports [Sci Rep] 2021 Nov 02; Vol. 11 (1), pp. 21427. Date of Electronic Publication: 2021 Nov 02.
Autor:
Hernandez M; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain.; Red Temática de Investigación Cooperativa Sanitaria en Enfermedades Oculares (Oftared), 31008 Pamplona, Spain., Recalde S; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain.; Red Temática de Investigación Cooperativa Sanitaria en Enfermedades Oculares (Oftared), 31008 Pamplona, Spain., González-Zamora J; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain., Bilbao-Malavé V; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain., Sáenz de Viteri M; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain.; Red Temática de Investigación Cooperativa Sanitaria en Enfermedades Oculares (Oftared), 31008 Pamplona, Spain., Bezunartea J; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain., Moreno-Orduña M; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain., Belza I; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain., Barrio-Barrio J; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.; Red Temática de Investigación Cooperativa Sanitaria en Enfermedades Oculares (Oftared), 31008 Pamplona, Spain., Fernandez-Robredo P; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain.; Red Temática de Investigación Cooperativa Sanitaria en Enfermedades Oculares (Oftared), 31008 Pamplona, Spain., García-Layana A; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain.; Red Temática de Investigación Cooperativa Sanitaria en Enfermedades Oculares (Oftared), 31008 Pamplona, Spain.
Publikováno v:
Nutrients [Nutrients] 2021 Apr 23; Vol. 13 (5). Date of Electronic Publication: 2021 Apr 23.
Autor:
Bilski, Rafał1 (AUTHOR) rafal.bilski@cm.umk.pl, Kupczyk, Daria1 (AUTHOR), Woźniak, Alina1 (AUTHOR) rafal.bilski@cm.umk.pl
Publikováno v:
Molecules. Nov2024, Vol. 29 Issue 22, p5460. 15p.